Publication:
Cesarean section scar pregnancy treatment - Case report

dc.contributor.authorNejković, L. (55566568600)
dc.contributor.authorPažin, V. (24169602000)
dc.contributor.authorFilimonović, D. (23990830300)
dc.date.accessioned2025-06-12T21:26:04Z
dc.date.available2025-06-12T21:26:04Z
dc.date.issued2013
dc.description.abstractThis is a case report of a 36-year-old patient with an ectopic pregnancy located in the previous cesarean section scar following in vitro fertilization (IVF). The patient was treated by 50 mg of intrasacular methotrexate locally under ultrasound guidance. Transvaginal ultrasound (TVUS) confirmed that the pregnancy was no longer vital within 24 hours, dilatation and aspiration of the ovular tissue were performed after seven days and it was sent for pathohistological analysis. Eight hours after the procedure, the patient began bleeding abundantly and was consequently treated locally by 1 ml of Beriplast® P Combi set, human fibrinogen, and human thrombin set (CSL Behring). After the treatment, the patient was discharged in good health, with normal laboratory values. Her menstrual period resumed 35 days after the procedure.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84879582052&partnerID=40&md5=edfa7cb7ea00f87b441b1d8e6edbac32
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9312
dc.subjectCesarean section scar
dc.subjectEctopic pregnancy
dc.subjectMethotrexate
dc.titleCesarean section scar pregnancy treatment - Case report
dspace.entity.typePublication

Files